Hotline:+86 2864841719
Outbound Sales&Marketing
 
Cynthia 
Tel: +86 2864841719 
Mobile: +86 17390183901 (English) 
Skype/Wechat:+86 18716376478
 
Mr. Yang  
Tel: +86 2884871826
Mobile: +86 13908183771   
Email: yangcx@enlaibio.com
 
Amy 
Tel: 028-84841969
Mobile:15884568590
QQ:551604319
Email:Amy@enlaibio.com

Bob
Tel:18980456393
Email:edison@enlaibio.com
QQ:3054240163
 
Daisy   
Tel:18314163848  
Email:daisy@enlaibio.com
QQ:2065506070

Industry News Your current location:Homepage >Industry News
请添加图片
First line treatment for chronic lymphocytic leukemia

As a first line treatment drugs for chronic lymphocytic leukemia, Ibrutinib improves survival compared with Ofatumumab in patients with previously treated Chronic Lymphocytic Leukemia.

From Poverty to Harvard Postdoc2013-10-24

Fingerprints Expose Chemical Identities 2019-01-04

2019 CPHI Shanghai Bio-Pharm Expo 2019-08-18